Against the backdrop of the nation’s highest inflation rate in 40 years, increased costs for gas, food, and household utilities, and rising violent crime rates, one study presented at the Alzheimer’s Association International Conference earlier this year shows that among lower-income communities of color, individual reactions to these life stressors may impact cognitive function and white…
Biogen’s new Alzheimer’s drug lecanemab has gotten the headlines recently. But it’s not the only good news on the dementia front. Far from it. Some might even say we’re making as much progress, or more, outside the drug labs as inside. I’ve already written about the power of walking, crosswords, and meditation to lower your…
Talk about food for thought. A growing body of research suggests that ultra-processed foods like frozen pizzas and breakfast cereals high in sugars, fats and empty calories are bad for your health. Now, a new large-scale study presented at the 2022 Alzheimer’s Association International Conference in San Diego this week offers more evidence that people…
Eisai 4523, -6.22% plans to share additional data about the Alzheimer’s disease treatment it’s developing with Biogen Inc. BIIB, -4.34% at an eagerly anticipated presentation this week. The Japanese drugmaker is set to present the findings from a Phase 3 clinical trial evaluating lecanemab as a treatment for people with early Alzheimer’s disease on Tuesday…